Coumarin 480 is a fluorescent dye that exhibits bright blue fluorescence upon excitation with ultraviolet light. It is widely used in various applications, including fluorescence microscopy, flow cytometry, and bioimaging. Coumarin 480 is synthesized through a multi-step process involving the condensation of 7-hydroxycoumarin with a suitable aromatic aldehyde. The dye exhibits high quantum yield and photostability, making it suitable for long-term fluorescence imaging. It is particularly useful for studying cellular processes, protein dynamics, and molecular interactions. Coumarin 480 has been used to label various biological targets, including proteins, nucleic acids, and lipids. Its ability to penetrate cell membranes allows for the visualization of intracellular structures and dynamics. Coumarin 480 is also used as a probe for detecting specific ions, such as calcium, and for monitoring enzymatic reactions. The compound's high fluorescence intensity and relatively long fluorescence lifetime make it a valuable tool for a wide range of biological and chemical research.'
coumarin 480: structure in first source
ID Source | ID |
---|---|
PubMed CID | 94517 |
CHEBI ID | 51774 |
SCHEMBL ID | 394375 |
MeSH ID | M0575524 |
Synonym |
---|
AKOS002345301 |
1h,5h,11h-[1]benzopyrano[6,7,8-ij]quinolizin-11-one, 2,3,6,7-tetrahydro-9-methyl- |
2,3,6,7-tetrahydro-9-methyl-1h,5h,11h-(1)benzopyrano(6,7,8-ij)quinolizin-11-one |
ccris 4960 |
brn 1220752 |
1h,5h,11h-(1)benzopyrano(6,7,8-ij)quinolizin-11-one, 2,3,6,7-tetrahydro-9-methyl- |
einecs 255-285-6 |
c 102 |
nsc 290431 |
coumarin 480 |
2,3,5,6-1h,4h-tetrahydro-8-methylquinolazino-(9,9a,1-gh)coumarin |
nsc290431 |
41267-76-9 |
nsc-290431 |
exciton 480 |
coumarin 102 |
1h,11h-[1]benzopyrano[6,7,8-ij]quinolizin-11-one, 2,3,6,7-tetrahydro-9-methyl- |
coumarin 102, dye content 99 % |
OPREA1_258576 |
STK325582 |
9-methyl-2,3,6,7-tetrahydro-1h,5h,11h-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-11-one |
CHEBI:51774 |
2,3,6,7-tetrahydro-9-methyl-1h,5h,11h-[1]benzopyrano[6,7,8-ij]quinolizin-11-one |
C2267 |
BBL010577 |
0m1gi783qt , |
unii-0m1gi783qt |
DTXSID9068293 |
mfcd00041844 |
SCHEMBL394375 |
coumarin102 |
k-102 |
CCG-251258 |
2,3,6,7-tetrahydro-9-methyl-1h,5h-quinolizino(9,1-gh)coumarin |
coumarin-102 |
9-methyl-2,3,6,7-tetrahydro-1h-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-11(5h)-one |
FT-0701397 |
6-methyl-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(17),2(7),5,8-tetraen-4-one |
Q27122741 |
8-methyl-2,3,5,6-tetrahydro-1h,4h-11-oxa-3a-aza-benzo(de)anthracen-10-one |
T70892 |
CS-0313534 |
9-ethyl-2,3,6,7-tetrahydro-1h-pyrano[2,3-f]pyrido[3,2,1-ij] |
quinolin-11(5h)-one |
Role | Description |
---|---|
fluorochrome | A fluorescent dye used to stain biological specimens. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
7-aminocoumarins | Any member of the class of coumarins that contains a 7-amino-2H-chromen-2-one skeleton. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (90.91) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.32) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |